ALC · Alcon AG
Price
Snapshot
50 fields · last close| Market Cap | $27.35B |
| P/E | 40.47 |
| Float | 486.5M |
| Beta | 1.07 |
| Volatility | 26.6% |
| Exchange | SIX |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 80.7 |
| Price | 67.69 |
| Change | +2.36% |
| Prev Close | 66.13 |
| Open | 65.50 |
| Day Low | 65.44 |
| Day High | 66.16 |
| Avg Vol | 1 |
| Avg $ Vol | $61.75M |
| 52W High | 87.18 |
| 52W Low | 47.80 |
| 52W Pos | 50.5% |
| From High | −22.36% |
| From Low | +41.61% |
| Max DD 1Y | −28.86% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +4.86% |
| SMA 50 | −0.98% |
| SMA 200 | −6.53% |
| RSI (14) | 52.7 |
| Vol 30D | 23.6% |
| Vol 90D | 25.2% |
| 1Y Range | 48–87 |
| Daily bars | 900 |
| Perf Week | +2.77% |
| Perf Month | +1.68% |
| Perf Quarter | −1.81% |
| Perf Half Y | −17.65% |
| Perf Year | −12.29% |
| Perf YTD | −12.77% |
| Prev Day | +2.36% |
| Clavix | B+ |
| Debt / Eq | 0.24 |
| Curr Ratio | 2.12 |
| Int Cover | 3.1× |
| FCF Margin | 14.3% |
| Rev Growth | +8.7% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 13 / 49 |
Clavix risk grade
regraded every trading dayALC grades B+, 80.7 of 100. Steadiest on Price Stability (66), most exposed on Sector Resilience (60, mixed). 1 of the 4 weighted dimensions sit above the Health Care median. Ranks 13 of 49 in Health Care by Clavix score.
How rough the ride is
| ALC | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.07 | 0.84 |
| Volatilityannualized | 26.6% | 20.9% |
| Max drawdown, past yearworst peak-to-trough fall | −28.9% | — |
| Typical daily movemedian absolute daily change | 0.94% | — |
| Days beyond ±3%of the last 252 sessions | 16 (6%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| ALC | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.07 | 0.84 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| ALC | |
|---|---|
| 1 week | +2.8% |
| 1 month | +1.7% |
| Year to date | −12.8% |
| 1 year | −12.3% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| ALC | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 8 Jul |
| Average score0 most bearish, 100 most bullish | 65 |
| Bullish · bearisharticles above 60 · below 40 | 22 · 3 |
| Directionarticles whose tone is improving vs worsening | 22 ↑ 3 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| ALC | |
|---|---|
| Revenue growthyear over year | +8.7% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openThe FDA approved Brytly, a new Alcon over-the-counter eye drop containing apraclonidine 0.125%, for treating eye redness from minor irritations in adults and children 12 and older. It is the first nonprescription eye drop with apraclonidine, and is limited to twice-daily use.
Alcon Media Group has launched a new international studio division led by former Amazon executive Diego Piasek and is planning to adapt some of its films, including 'Insomnia' and 'Prisoners,' into UK television series, with details to be presented at the Mipcom TV market.
Alcon announced the launch of Systane® PRO Preservative-Free, a new over-the-counter eye drop, in Canada. The product is described as a triple-action formula providing up to 12 hours of dry eye symptom relief and contains no preservatives.
The article body is truncated, so the full valuation argument is not available.
AMC and French broadcaster Canal+ have officially greenlit a Point Break television series from Alcon Entertainment, based on the 1991 Patrick Swayze and Keanu Reeves surf heist film, set in the present day more than thirty years later.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| DGX | Quest Diagnostics Inc | A- | $25.93B | 24.38 | 0.56 | Compare |
| LH | Labcorp Holdings Inc | A- | $25.86B | 25.80 | 0.89 | Compare |
| GEHC | GE Healthcare Technologies Inc | B | $31.51B | 15.87 | 0.83 | Compare |
| DXCM | Dexcom Inc | B | $32.45B | 32.48 | 1.44 | Compare |
| RMD | Resmed Inc | B+ | $33.72B | 22.10 | 0.77 | Compare |
| CNC | Centene Corp | B | $33.90B | — | 1.08 | Compare |
| STE | STERIS plc | A- | $21.64B | 26.84 | 0.88 | Compare |
| THC | Tenet Healthcare Corp | B | $21.45B | 9.60 | 1.22 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.